Analyzing Global Medical REIT's Ex-Dividend Date


Global Medical REIT GMRE declared a dividend payable on July 8, 2021 to its shareholders as of June 10, 2021. It was also announced that shareholders of Global Medical REIT's stock as of June 24, 2021 are entitled to the dividend. The stock is expected to become ex-dividend 1 business day(s) before the record date. Global Medical REIT has an ex-dividend date planned for June 23, 2021. The company's current dividend payout sits at $0.2. That equates to a dividend yield of 5.2% at current price levels.

What Are Ex-Dividend Dates?

Ex-dividend dates are when company shares stop trading with their current dividend payouts in preparation for those companies to announce new ones. Usually, a company's ex-dividend date falls one business day before its record date. Investors should keep this in mind when purchasing stocks because buying them on or after ex-dividend dates does not qualify them to receive the declared payment. Newly declared dividends go to shareholders who have owned that stock before the ex-dividend date. Typically, companies will announce and implement new dividend yields on a quarterly basis.

Understanding Global Medical REIT's Dividend History

Over the past year, Global Medical REIT has seen its dividend payouts remain the same and its yields trend downward. Last year on June 24, 2020 the company's payout sat at $0.2, which has returned to its value today. Global Medical REIT's dividend yield last year was 7.23%, which has since decreased by 2.03%.
Companies use dividend yields in different strategic ways. Some companies may opt to not give yields altogether to reinvest in themselves. Other companies may opt to increase or decrease their yield amounts to control how their shares circulate throughout the stock market.

To read more news on Global Medical REIT click here.

Market News and Data brought to you by Benzinga APIs
Posted In: DividendsBZI-ExDiv
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!